30 October 2023 | News
With a proven track record of fostering sustainable business growth in the pharmaceutical space
Sami-Sabinsa Group, a multi-national health science company headquartered in Bengaluru, has announced the appointment of Dr Vijaya Kumar S as its Chief Executive Officer (CEO).
A well-known professional in the industry, Dr Vijaya Kumar has a proven track record of fostering sustainable business growth in the pharmaceutical space. He has held leadership positions across large organisations such as Saurav Chemicals, Biocon, Centrient, Aurobindo, Dr. Reddy’s, Mckinsey, Novartis, GSK, and others.
With an illustrious career of 35 years in research and development, manufacturing, operations, and management, he brings a wealth of experience to his new role as the CEO of Sami-Sabinsa Group.
Dr Kumar has a depth of experience in manufacturing science, plant and process engineering, process analytics, plant automation, regulatory frameworks, and CAPEX management.
He is passionate about leveraging continuous improvement methodologies as Lean Sigma and Kaizen and delivering process improvements in his assignments.
Dr Vijaya Kumar has completed his postgraduate in management from National University of Singapore and holds a doctorate degree in chemical engineering from Indian Institute of Science (IISc).